Latest Breaking News On - Phanes therapeutics - Page 1 : comparemela.com

Phanes Therapeutics, Inc. Announces Clinical Supply Agreement with Roche to Evaluate PT217 in Combination with an anti-PD-L1 Therapy

Phanes Therapeutics, Inc. Announces Clinical Supply Agreement with Roche to Evaluate PT217 in Combination with an anti-PD-L1 Therapy
mtdemocrat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mtdemocrat.com Daily Mail and Mail on Sunday newspapers.

Rita-laeufle
Phanes-therapeutics-inc
Fast-track
Phanes-therapeutics
Chief-medical-officer

FDA fast tracks investigational bispecific therapy for aggressive lung cancer

FDA fast tracks investigational bispecific therapy for aggressive lung cancer
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Bydrew-amorosi
Mindy-valcarcel
Ming-wang
Phanes-therapeutics

FDA Grants Fast Track Designation to PT217 for Extensive Stage Small Cell Lung Cancer

The FDA has granted fast track designation to PT217 for patients with extensive stage small cell lung cancer with disease progression.

Ming-wang
Phanes-therapeutics
Fda
Extensive-stage-small-cell-lung-cancer-es-sclc
Lung-cancer
Pt217-
Phase-1-skybridge-trial-nct05652686-

Phanes Therapeutics' PT217 granted Fast Track Designation by the FDA

/PRNewswire/ Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology,.

Ming-wang
Drug-administration
Phanes-therapeutics-inc
Phanes-therapeutics
Fast-track

FDA Grants Fast Track Designation to PT886 for the Treatment of Pancreatic Cancer

PT886 (Phanes Therapeutics) received fast track designation 2 years after receiving orphan drug designation by the FDA.

United-states
Ming-wang
Phanes-therapeutics-inc
Phanes-therapeutics
Patients-with
Advanced-gastric
Gastroesophageal-junction
Fast-track
Therapeutics-announces-first-patient-dosed
Announces-clinical-trial-collaboration
Supply-agreement